This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia Corporation. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: The Innovations of David Limburg
Introduction
David Limburg is an accomplished inventor based in Wildwood, MO (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that address inflammatory conditions. His work has led to the creation of a patent that showcases his innovative approach to treating cyclooxygenase-2 mediated disorders.
Latest Patents
David Limburg holds a patent for "Benzopyran compounds useful for treating inflammatory conditions." This invention focuses on methods and compounds that have utility in treating conditions associated with cyclooxygenase-2 mediated disorders. The compounds of particular interest in his patent are benzopyrans and their analogs, which are defined by a specific formula. This innovative approach has the potential to provide new therapeutic options for patients suffering from inflammatory diseases.
Career Highlights
Throughout his career, David has worked with Pharmacia Corporation, where he has been able to apply his expertise in medicinal chemistry. His dedication to research and development has led to advancements in the pharmaceutical industry, particularly in the area of anti-inflammatory treatments. With a patent portfolio that includes 1 patent, David has established himself as a notable figure in his field.
Collaborations
David has collaborated with several professionals in his field, including Jeffry Carter and David Louis Brown. These collaborations have allowed him to enhance his research and contribute to the development of innovative solutions in medicine.
Conclusion
David Limburg's contributions to the field of medicinal chemistry and his innovative patent for benzopyran compounds highlight his commitment to improving treatment options for inflammatory conditions. His work continues to inspire advancements in pharmaceutical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
